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Summary 
Reynaldi, F., G. Albo, E. Avellaneda & R. Rule, 2016. Evaluation of kinetic behaviour of 
two preparations of tylosin administered in beehives for American foulbrood control. Bulg. 
J. Vet. Med. (online first). 
 
We compared the kinetic behaviour of tylosin administered to beehives by dusting or paper-pack 
placement through three treatment protocols (D, PP, CONTROL). D (dusting): tylosin, divided in 
four portions, was sprinkled over the ends of the hives' top bars weekly for four weeks (n=3); PP 
(paper-pack placement): tylosin in paper packs was administered at two-week intervals (n=3); 
CONTROL (control): the hives were left untreated (n=3). In every inspection, from each of the nine 
hives, fifty young (2-day-old) larvae were sampled for drug analysis. The concentration of tylosin in 
the young larvae was determined by a microbiological assay with Geobacillus stearothermophilus 
ATCC 12980 as test organism. The (mean±SD) maximum concentration (Cmax) for D was 
136.0±194.0 and for PP – 144.0±187.4 µg/mL; the time to reach Cmax (tmax) was 1.5±0.9 h for D and 
1.8 ± 1.8 h for PP. The area under the tylosin behaviour kinetics curve between 0–1392 h with D was 
308.7±185.2 and with PP: 326.4±141.0 µg/h/mL, indicating no statistical difference between the 
treatments (P>0.05). The shorter duration of paper-pack-administered tylosin observed in the larvae 
implied a lower risk of antibiotic residues in the resulting honey. 
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INTRODUCTION 
American foulbrood disease (AFB), cau-
sed by the spore-forming, Gram-positive 
rod-shaped bacterium Paenibacillus lar-
vae (Genersch et al., 2006); is a devasta-
ting brood disease that can affect both the 
larval and pupal stages of honeybees (Apis 
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mellifera L.). The unique characteristics 
of the spores, which can remain viable for 
long periods of time and survive adverse 
environmental conditions (Matheson & 
Reid, 1992; Shimanuki & Knox, 2000), 
make the AFB a highly contagious and 
also widespread disease. The control of 
AFB must be aboard taking into account a 
global scenario such as infection level, 
disease incidence, and the use of antibio-
tics or other natural substances for con-
trolling this pest. In areas where disease 
incidence in low and infection levels is 
moderate, a shook swarm methods of 
treatment is recommended (Von der Ohe, 
2003). However in areas where disease 
incidence is high antibiotic treatment is a 
possible alternative for the control of the 
disease. Thus, several honey producers 
countries (e.g. Argentina, Canada, China 
and USA between others) allow the use of 
antibiotics to keep the disease under con-
trol (Reybroeck et al., 2012). Oxytetracy-
cline (OTC) and tylosin are the only anti-
biotics approved for the control of AFB in 
bee hives, nonetheless the high selection 
pressure because of the intensive use of 
OTC in professional beekeeping, added to 
the fact that OTC having been also used 
against Melisococcus plutonius (Oldroy et 
al., 1989; Thompson et al., 2005) possibly 
favoured the oxytetracycline-resistant P. 
larvae isolates in Argentina (Alippi, 
2000), Canada (Colter, 2000) and the 
USA (Miyagi et al, 2000). In addition, the 
efficacy of tylosin has already been 
proven through the use of different appli-
cation methods (dusting or the placement 
in paper-packs, syrupy sugar, and patties) 
by different authors (Hitchcock et al., 
1970; Peng et al., 1996; Alippi et al., 2005; 
Pettis & Feldlaufer, 2005; Reynaldi et al., 
2009). This feature makes tylosin an al-
ternative for the control of infected hives 
with oxytetracycline-resistant isolates.  
On the other hand, since honeybees 
are classified as food producing animals 
but, as no metabolism exists inside a bee-
hive, maximum residues limit (MRL) of 
honey cannot be defined (Reybroeck et 
al., 2012). In the absence of either MRL 
or reference points for action (RPA), the 
presence of any detectable (and con-
firmed) residues in honey prevents this 
product from being legally placed in a 
market such as the EU (Anonymous, 
2009). For this reason, the study of di-
verse pharmacokinetics parameters, such 
as the binding protein (Reynaldi et al., 
2010a), minimal bactericidal concentra-
tion (MBC), MBC/MIC relationship, kil-
ling curves (Reynaldi et al., 2010b)  or 
bioavailability, could help define the best 
treatment that must be not only efficient, 
but also safe for honey production. 
The aim of the present work was there-
fore to study the kinetic behaviour of ty-
losin between the two most common 
methods of application of tylosin in the 
field trials, dusting and paper-pack. 
MATERIALS AND METHODS 
Field assay 
The assay was conducted at the experi-
mental field of the School of Agricultural 
Science, UNLP, La Plata (35.8º S, 5.8º 
W). All honeybee colonies, derived from 
Apis mellifera ligustica L., were standar-
dised to contain 25,000 adult bees, 6 
combs of brood (2 open and 4 sealed 
broods), 2 combs containing honey and 
pollen, and 2 combs of wax. The queens 
were marked and their wings clipped to 
avoid swarming. The colonies were dis-
tributed in a completely randomised de-
sign and none had been treated with anti-
biotics for the last ten years. Three treat-
ments were then randomly assigned to the 
hives. (1) Treatment PP (paper-pack pla-
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cement) involved a combination of 114 g 
of confectioner’s sugar, 5 g of cherry, and 
1 g of tylosin tartrate (Vetifarma®). The 
entire admixture (121 g) was divided be-
tween two paper-packs of about 60 g 
each, those being applied over the ends of 
the top bars of the hives for a total of four 
weeks at two-week intervals. (2) Treat-
ment D (dusting) consisted of combining 
114 g of confectioner’s sugar, 5 g of 
cherry jelly (used as an attractant to pro-
mote consumption), and 1 g of tylosin 
tartrate (Vetifarma®). The admixture was 
divided into four 30 g portions. Each ap-
plication consisted in a sprinkling one 
portion over the ends of the top bars for a 
total of four weeks at one-week intervals. 
The control group consisted of a set of 
untreated hives. Three hives were ran-
domly assigned to each experimental 
group. The present work was approved by 
the Ethic Committee of the Faculty of 
Agricultural Sciences and Forestry, Na-
tional University of La Plata, Argentina 
Sampling and preservation of samples 
In every inspection, fifty young (2-day-
old) larvae (YLs) from each of the nine 
hives were sampled for drug analysis. For 
the interval of delivery of the antibiotic 
during the first four weeks, with both 
forms of administration (e. g., dusting and 
paper-pack), samples were taken on days 
2, 4, and 6 of each week; and from the 
fifth week onwards, the collection of lar-
vae was performed weekly until the end of 
the three months of the experiment. Sam-
ples were stored at –20 °C until further 
analysis. 
Quantification of the antibiotic 
The concentrations of tylosin tartrate in 
YL were determined by microbiological 
assay using Geobacillus stearothermophi-
lus ATCC 12980 as test organism (Herbst, 
1982; Rule et al., 2014). Each sample was 
assayed for tylosin by an agar diffusion 
bioassay with Mueller Hinton Agar (Lab. 
Britania, Argentina) seeded with the Geo-
bacillus stearothermophilus (1×106) and 
allowed to solidify on 23×28 cm glass 
plates. Duplicate 25-μL portions of each 
sample and of the standards were then 
placed in 6 mm wells cut into the seeded 
agar. The tylosin standards (20.0, 10.0, 
5.0, 2.5, 1.0, 0.5, 0.25, 0.125, 0.06, 0.03, 
0.01, 0.006, 0.003, 0.001 µg/g) were pre-
pared in YL taken from an untreated hive. 
After incubation of the assay plates for 6 
to 8 hours at 64 °C, the zone of inhibition 
around each well was measured and stan-
dard curves were prepared. Sampling be-
fore administration of the antibiotic 
showed no bacterial inhibition. The corre-
lation coefficient for the standard curves, 
the intra- and interassay coefficients of 
variation, the sensitivity and quantifica-
tion limits of the assay were calculated 
according to Reynaldi et al. (2010a). 
Briefly, the correlation coefficient for the 
standard curves prepared for all the ex-
periments was >0.98. Intra- and interassay 
coefficients of variation were lower than 
8%. Sensitivity and quantification limits 
of the assay for YL was 0.001 μg/mL. No 
inhibition zones were observed in samples 
from control beehives. 
Pharmacokinetic analysis and statistics 
The pharmacokinetic analysis of the data 
was performed by means of a non-
compartmental model, according to the 
methods described by Gibaldi & Perrier 
(1982). The maximum concentration 
(Cmax) of tylosin in YLs and the time to 
reach Cmax (tmax) are empirical values 
taken directly from the analytical data. 
The area under the curve (AUC) of con-
centration with respect to time was calcu-
lated by trapezoidal methods. The statisti-
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cal comparisons of the pharmacokinetic 
parameters were made by means of a two-
way analysis of variance (Statgraphic Plus 
7.0). A probability level of less than 0.05 
was considered statistically significant. 
RESULTS  
Fig. 1 shows the concentration-time cur-
ves of tylosin in YLs after either treatment 
PP (A) or treatment D (B). The mean±SD 
values for Cmax for treatments PP and D 
were 136.0±194.0 µg/mL and 144.0± 
187.4 µg/mL respectively. The tmax of ty-
losin was 1.5±0.9 h (treatment PP) and 
1.8±1.8 h (treatment D). No statistical 
differences in either the Cmax or the tmax 
between treatments were found. The AUC 
obtained from time 0 to 1392 h for treat-
ment PP was 308.7±185.2 µg/h/mL and 
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Fig. 1. Concentration-time curves of tylosin in young Apis mellifera larvae administered either in a 
paper pack (A) or by dusting (B). The mean larval tylosin concentration (µg/mL) is plotted on the 
ordinate as a function of time in days on the abscissa. The minimum inhibitory concentration (MIC90) 
for the growth of Paenibacillus larvae (Alippi et al., 2005) is indicated by a horizontal line. The 
arrows above the curves, point the days on which tylosin doses were added to the hives. 
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for treatment D: 326.4±141.0 µg/h/mL, 
with likewise no statistical difference oc-
curring  between the two modes of tylosin 
administration (P≥0.05). With treatment 
PP the antibiotic became undetectable on 
day 62, while with treatment D the corre-
sponding time was day 76. 
DISCUSSION 
The efficacy of several antibiotics such as 
tylosin, lincomycin (Okayama et al., 1996; 
Kochanski et al., 2001) or even more re-
cently tilmicosin (Reynaldi et al., 2008) 
have been tested against OTC-resistant 
strains (Alippi, 2000; Colter, 2000; Mi-
yagi et al., 2000). Among them, tylosin 
appeared as an attractive alternative ex-
hibiting both a bactericidal effect and the 
best in vitro inhibition of P. larvae in 
terms of the MIC, MBC, and MBC/MIC 
values (Peng et al., 1996; Alippi et al., 
2005; Reynaldi et al., 2010b). Further-
more, the field efficacy of tylosin had al-
ready been demonstrated by several au-
thors (Elzen et al., 2002; Alippi et al., 
2005; Pettis & Feldlaufer, 2005). How-
ever, the consumption of tylosin was a 
trouble, for this reason, Peng et al. (1996) 
recommended the use of cherry jelly as an 
attractant to improve the palatability of 
tylosin treatment. More recently, Reynaldi 
et al. (2009) have demonstrated the effec-
tiveness of 1 g of tylosin tartrate as the 
lowest dose for eliminating disease symp-
toms in beehives, with no recurrence be-
ing observed for up to a year. 
In general, an antibiotic would need to 
remain for a certain time within the hive, 
after which period the agent should be 
removed from the hive so as to reduce the 
chance of leaving residues in the honey. A 
limited period of exposure to the antibi-
otic would also avoid the chance of selec-
ting resistant mutant bacteria because, 
leaving antimicrobial concentrations in-
side the mutant window selection de-
scribed by Drilca (2003), is expected to 
enrich resistant subpopulations. Even 
though the kinetics parameters showed no 
statistical differences between treatments, 
treatment PP remained less time below the 
MIC, thus minimising the chance of ena-
bling mutant selection. Antibiotics per se 
do not induce a resistance, but simply 
provide the selective force to promote the 
Darwinian process of natural selection. 
The mutation potential, the genetic inter-
change between bacteria, added to the 
limited time of bacteria generating to-
gether with a wrong therapeutic applica-
tion can rapidly produce resistant popula-
tions (Drilca, 2003). For this reason, be-
tween the two field treatments (paper-
pack and dusting) with the same resulting 
efficiencies of action, the treatment of 
choice would be the use of paper packs 
because the concentrations of the antibi-
otic remained in the hive for 14 days less 
than with the application by dusting.  
CONCLUSION 
The intention of the present study was to 
determine the kinetic behaviour of tylosin 
in beehives in order to generate a useful 
strategy for the employment of antibiotics 
as bactericidal agents for the control of 
American Foulbrood in beehives. Accor-
dingly, the concentrations of tylosin in the 
YLs indicated that although both forms of 
delivery – via paper pack or by dusting – 
had proven effective in controlling AFB 
in previous field trails (Hitchcock et al., 
1970; Peng et al., 1996; Alippi et al., 
2005; Reynaldi et al., 2010b), the more 
rapid elimination of tylosin applied by 
paper pack made this treatment the better 
one. The more time a microorganism 
spends at sub-inhibitory concentrations, 
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the greater the chances of selection for a 
resistant microorganism. Treatment PP 
proved to be easy to use by the beekeep-
ers; moreover the treatment required only 
two visits to the apiary, as opposed to the 
four needed with dusting. 
To date, the use of antimicrobial 
agents in apiculture has been indiscrimi-
nate and the pharmacological and chemo-
therapeutic data available in bees are lim-
ited. Consequently, all the information 
related to this topic such as relative 
bioavailability studies, percentages of 
binding protein for antibiotics, MIC, 
MBC, the MBC/MIC ratio, killing curves 
and the kinetic behaviour presented here 
would be useful in developing treatments 
that should be both efficient and safe for 
honey production. 
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